Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer — Stella

Home/Rectal Neoplasm Malignant/Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer

View on ClinicalTrials.gov

Recruiting

Back to Rectal Neoplasm Malignant trials

Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer

Trial locations(1 site)

Taiwan

Linkou Chang Gung Memorial Hospital, Guishan, Taoyuan

Key details

Sponsor

Chang Gung Memorial Hospital

Enrollment target

~250 participants

Started

January 2024

Primary completion

December 2028

Age range

20 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.